Biopharmaceutical Excipients Companies

Ashland Introduces Polyplasdone Plus, a Multifunctional Superdisintegrant: In June 2023, Ashland introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant that combines the functionalities of a glidant and a lubricant in a single excipient.

Lubrizol Life Science Health Wins Award for Apisolex Polymer Excipient: In October 2023, Lubrizol Life Science Health was awarded the Finished Formulation Award at CPhI Barcelona for its Apisolex Polymer solubilizing excipient.

DFE Pharma Expands Dry Powder Inhalation (DPI) Portfolio: In July 2022, DFE Pharma announced the launch of Lactohale 400, a new excipient specifically designed for dry powder inhalation (DPI) formulations.

Evonik Industries Invests in Expansion of Excipient Production Capacity: In September 2023, Evonik Industries announced plans to invest €200 million to expand its production capacity for cellulose-based excipients at its site in Antwerp, Belgium.

• Merck KGaA (Germany)


• Colorcon (BPSI Holdings Inc)(.S)


• BASF SE(Germany)


• Associated British Foods plc (UK)


• Signet Excipients Pvt. Ltd (IMCD) (Netherlands)


• Sigachi Industries Limited (India)


• Spectrum Chemical Manufacturing Corp. (US)


• Roquette Frères (France)


• Clariant (Switzerland)


• DFE Pharma (Germany)


• Rettenmaier & SöhneGmbh + Co Kg (Germany)


• Evonik Industries AG (Germany)